BEAM:BMV
Beam Therapeutics Inc
MX$453.00
0.00%
(0.00) 1D
Oct 8, 7:30:20 AM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Mkt. cap
2.65B
Avg. vol.
13.00
Volume
0.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
540
Mkt. cap
2.65B
Avg. vol.
13.00
Volume
0.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
540
News stories
From web sources and news partners
FXLeaders
·
1 hour ago
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
CryptoRank
·
8 hours ago
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
Hindustan Times
·
5 hours ago
Why are 54% of US stocks down 20% as the S&P 500 nears a record high? | Hindustan Times
Traders Union
·
3 hours ago
Yuriy Matso: S&P500 negative beta to SPY at record 18.9 percent
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc